Quantum Biopharma (QNTM) Receivables - Net (2018 - 2025)
Quantum Biopharma (QNTM) reported Receivables - Net of $231053.0 for Q4 2025, down 38.33% on a YoY basis from $374678.0 in Q4 2024, and down 38.33% sequentially from $374678.0 in Q4 2024.
Quantum Biopharma (QNTM) Receivables - Net (2018 - 2025) Analysis & Trends
Quantum Biopharma (QNTM) has 8 years of Receivables - Net data on file, last reported at $231053.0 in Q4 2025.
- For the quarter ending Q4 2025, Receivables - Net fell 38.33% year-over-year to $231053.0; the trailing twelve-month figure through Dec 2025 stood at $231053.0 (down 38.33% YoY), and the FY2025 full-year result was $231053.0, down 38.33% from the prior year.
- Receivables - Net fell to $231053.0 in Q4 2025, from $374678.0 in the prior quarter.
- In the past five years, Receivables - Net ranged from a high of $500964.0 in Q4 2021 to a low of -$341916.0 in Q2 2021.
- A 5-year average of $138364.0 and a median of $229908.5 in 2023 frame the typical range for Receivables - Net.
- Peak annual rise in Receivables - Net reached 210.5% in 2021, while the deepest fall reached 170.39% in 2021.
- Tracing QNTM's Receivables - Net over 5 years: stood at $500964.0 in 2021, then slipped by 25.27% to $374377.0 in 2022, then tumbled by 38.89% to $228764.0 in 2023, then surged by 63.78% to $374678.0 in 2024, then tumbled by 38.33% to $231053.0 in 2025.
- Business Quant data shows QNTM's Receivables - Net at $231053.0 in Q4 2025, $374678.0 in Q4 2024, and $228764.0 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Quantum Biopharma | 2.61 Bn | 2.60 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 231,053.00 |
| Dec 31, 2025 | 231,053.00 |
| Dec 31, 2024 | 374,678.00 |
| Dec 31, 2024 | 374,678.00 |
| Dec 31, 2023 | 228,764.00 |
| Dec 31, 2023 | 228,764.00 |
| Dec 31, 2022 | 374,377.00 |
| Dec 31, 2022 | 374,377.00 |
| Dec 31, 2021 | 500,964.00 |
| Dec 31, 2021 | 500,964.00 |
| Sep 30, 2021 | -208,114.00 |
| Sep 30, 2021 | -208,114.00 |
| Jun 30, 2021 | -341,916.00 |
| Jun 30, 2021 | -341,916.00 |
| Mar 31, 2021 | -52,894.00 |
| Mar 31, 2021 | -52,894.00 |
| Dec 31, 2020 | 161,342.00 |
| Dec 31, 2020 | 161,342.00 |
| Jun 30, 2020 | 485,760.43 |
| Jun 30, 2020 | 485,760.43 |